Browsing Tag
Swissmedic
3 posts
AGAMREE wins Swissmedic approval, positioning Santhera for broader Duchenne muscular dystrophy market expansion
Santhera wins Swissmedic approval for AGAMREE in Duchenne muscular dystrophy. Find out how this milestone could drive European expansion and investor sentiment.
KalVista Pharmaceuticals wins EU and Swiss approval for EKTERLY—what does this mean for the stock?
KalVista Pharmaceuticals secures EU and Swiss approval for EKTERLY, the first oral HAE therapy. Can this rare disease breakthrough lift KALV stock?
Switzerland becomes first country to grant full approval to Pfizer-BioNTech Covid-19 vaccine
Switzerland becomes the first nation to fully approve the Pfizer-BioNTech Covid-19 vaccine. Find out how Swissmedic's rigorous process could influence global vaccine confidence.